Literature DB >> 10534272

Nonvasculitic autoimmune inflammatory meningoencephalitis (NAIM): a reversible form of encephalopathy.

R J Caselli1, B F Boeve, B W Scheithauer, J D O'Duffy, G G Hunder.   

Abstract

Five patients, age 54 to 80 years, presented between 3 weeks and 18 months after symptomatic onset of progressive cognitive decline, psychosis, and unsteady gait that proved to be due to a steroid-responsive nonvasculitic autoimmune inflammatory meningoencephalitic syndrome. CSF examination showed elevated immunoglobulin (Ig)G index and IgG synthesis rate in all three patients in whom it was checked, and brain biopsy revealed perivascular lymphocytic infiltrates without vessel wall invasion.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10534272     DOI: 10.1212/wnl.53.7.1579

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  18 in total

1.  Autoimmune encephalopathy.

Authors:  Richard J Caselli; Joseph F Drazkowski; Dean M Wingerchuk
Journal:  Mayo Clin Proc       Date:  2010-10       Impact factor: 7.616

Review 2.  Hashimoto's encephalopathy : epidemiology, pathogenesis and management.

Authors:  Ramon Mocellin; Mark Walterfang; Dennis Velakoulis
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

3.  Steroid-responsive encephalopathy subsequently associated with Alzheimer's disease pathology: a case series.

Authors:  Farrah J Mateen; Keith A Josephs; Joseph E Parisi; Daniel A Drubach; Richard J Caselli; Kejal Kantarci; Clifford Jack; Bradley F Boeve
Journal:  Neurocase       Date:  2011-06-30       Impact factor: 0.881

4.  An adult norovirus-related encephalitis/encephalopathy with mild clinical manifestation.

Authors:  En Kimura; Hitomi Goto; Akie Migita; Seiya Harada; Satoshi Yamashita; Teruyuki Hirano; Makoto Uchino
Journal:  BMJ Case Rep       Date:  2010-10-18

Review 5.  Hashimoto's encephalopathy: a brief review.

Authors:  Howard S Kirshner
Journal:  Curr Neurol Neurosci Rep       Date:  2014-09       Impact factor: 5.081

6.  Autoimmune dementia: clinical course and predictors of immunotherapy response.

Authors:  Eoin P Flanagan; Andrew McKeon; Vanda A Lennon; Bradley F Boeve; Max R Trenerry; K Meng Tan; Daniel A Drubach; Keith A Josephs; Jeffrey W Britton; Jayawant N Mandrekar; Val Lowe; Joseph E Parisi; Sean J Pittock
Journal:  Mayo Clin Proc       Date:  2010-10       Impact factor: 7.616

Review 7.  Immunomodulatory therapies in neurologic critical care.

Authors:  Logan M McDaneld; Jeremy D Fields; Dennis N Bourdette; Anish Bhardwaj
Journal:  Neurocrit Care       Date:  2009-09-23       Impact factor: 3.210

8.  Transient life-threatening cerebral edema in a patient with systemic lupus erythematosus.

Authors:  Matt T Bianchi; Catherine Lavigne; Farzaneh Sorond; Bonnie Bermas
Journal:  J Clin Rheumatol       Date:  2009-06       Impact factor: 3.517

Review 9.  Rapidly progressive dementia.

Authors:  Michael D Geschwind; Aissa Haman; Bruce L Miller
Journal:  Neurol Clin       Date:  2007-08       Impact factor: 3.806

10.  A case of lymphomatosis cerebri mimicking inflammatory diseases.

Authors:  Takenobu Murakami; Kenji Yoshida; Mari Segawa; Akioh Yoshihara; Akihiko Hoshi; Koichiro Nakamura; Masahiro Ichikawa; Osamu Suzuki; Yuichi Yokoyama; Yasuko Toyoshima; Yoshihiro Sugiura; Hiroshi Ito; Kiyoshi Saito; Yuko Hashimoto; Akiyoshi Kakita; Hitoshi Takahashi; Yoshikazu Ugawa
Journal:  BMC Neurol       Date:  2016-08-08       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.